Skip to main content
Account

Peer review reports

From: Fatal interstitial lung disease associated with Crizotinib pathologically confirmed by percutaneous lung biopsy in a patient with ROS1-rearranged advanced non-small-cell lung cancer: a case report

Original Submission
24 Apr 2018 Submitted Original manuscript
28 Apr 2018 Author responded Author comments - Shibo Wu
Resubmission - Version 2
28 Apr 2018 Submitted Manuscript version 2
15 May 2018 Reviewed Reviewer Report - Samantha Aso
13 Jun 2018 Author responded Author comments - Shibo Wu
Resubmission - Version 3
13 Jun 2018 Submitted Manuscript version 3
27 Jun 2018 Author responded Author comments - Shibo Wu
Resubmission - Version 4
27 Jun 2018 Submitted Manuscript version 4
Publishing
2 Jul 2018 Editorially accepted
20 Jul 2018 Article published 10.1186/s12890-018-0682-9

Learn about peer review

Back to article page

Navigation